← Evidence map

ArticleMedicina (Kaunas, Lithuania)2025

Impact of Treatment Duration in First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Multicenter Real-World Retrospective Study.

Mehmet Nuri Baser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Impact of Treatment Duration in First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Multicenter Real-World Retrospective Study. | OpenQuestion